JP6916524B2 - 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 - Google Patents

機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 Download PDF

Info

Publication number
JP6916524B2
JP6916524B2 JP2017552146A JP2017552146A JP6916524B2 JP 6916524 B2 JP6916524 B2 JP 6916524B2 JP 2017552146 A JP2017552146 A JP 2017552146A JP 2017552146 A JP2017552146 A JP 2017552146A JP 6916524 B2 JP6916524 B2 JP 6916524B2
Authority
JP
Japan
Prior art keywords
linker
polypeptide
csga
item
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017552146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018517398A5 (enExample
JP2018517398A (ja
Inventor
ニール エス． ジョシ，
ニール エス． ジョシ，
ピーター キュー． グエン，
ピーター キュー． グエン，
アンナ ドゥラジ−タッテ，
アンナ ドゥラジ−タッテ，
ピチェト プラベスチョティノント，
ピチェト プラベスチョティノント，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of JP2018517398A publication Critical patent/JP2018517398A/ja
Publication of JP2018517398A5 publication Critical patent/JP2018517398A5/ja
Priority to JP2021030187A priority Critical patent/JP7156726B2/ja
Application granted granted Critical
Publication of JP6916524B2 publication Critical patent/JP6916524B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/101—Plasmid DNA for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2017552146A 2015-04-06 2016-04-06 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 Active JP6916524B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021030187A JP7156726B2 (ja) 2015-04-06 2021-02-26 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562143560P 2015-04-06 2015-04-06
US62/143,560 2015-04-06
PCT/US2016/026161 WO2016164422A2 (en) 2015-04-06 2016-04-06 Biosynthetic amyloid-based materials displaying functional protein sequences

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021030187A Division JP7156726B2 (ja) 2015-04-06 2021-02-26 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料

Publications (3)

Publication Number Publication Date
JP2018517398A JP2018517398A (ja) 2018-07-05
JP2018517398A5 JP2018517398A5 (enExample) 2019-05-16
JP6916524B2 true JP6916524B2 (ja) 2021-08-11

Family

ID=57072695

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017552146A Active JP6916524B2 (ja) 2015-04-06 2016-04-06 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料
JP2021030187A Active JP7156726B2 (ja) 2015-04-06 2021-02-26 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021030187A Active JP7156726B2 (ja) 2015-04-06 2021-02-26 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料

Country Status (4)

Country Link
US (2) US20180258435A1 (enExample)
EP (1) EP3280397A4 (enExample)
JP (2) JP6916524B2 (enExample)
WO (1) WO2016164422A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815871B2 (en) 2013-04-23 2017-11-14 President And Fellows Of Harvard College Genetic reprogramming of bacterial biofilms
JP6916524B2 (ja) 2015-04-06 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料
US11098133B2 (en) 2016-05-19 2021-08-24 President And Fellows Of Harvard College Methods of making gels and films using curli nanofibers
FR3099648B1 (fr) * 2019-07-30 2023-01-13 Centre Nat Rech Scient Membrane échangeuse d’ions
CN110585482B (zh) * 2019-08-02 2022-03-01 大连理工大学 一种具有抗菌性能的杂萘联苯聚芳醚腈及其表面改性方法
CN112608876B (zh) * 2020-12-30 2024-02-09 江苏大学 一种生物素化Curli蛋白的活细胞标记方法及其应用
GB202216905D0 (en) * 2022-11-11 2022-12-28 Oxford Nanopore Tech Plc Novel pore monomers and pores
KR102855274B1 (ko) * 2022-12-06 2025-09-08 충남대학교산학협력단 strep-tag 결합물질에 대한 결합능을 가지는 융합단백질을 암호화하는 유전자 구조물 및 이를 함유하는 발현벡터, 재조합 균주 및 항암 조성물

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762620A (en) 1992-04-02 1998-06-09 Ndm Acquisition Corp. Wound dressing containing a partially dehydrated hydrogel
US6864365B1 (en) * 1999-04-05 2005-03-08 Innovation And Development Corporation, University Of Victoria Bacterial fimbrial system for presentation of heterologous peptide sequences
DE60229867D1 (de) * 2001-07-02 2008-12-24 Merrion Res Iii Ltd Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
AU2003217415B2 (en) 2002-02-14 2009-01-08 William J Rutter Chimeric molecules for cleavage in a treated host
PL1626799T3 (pl) 2003-04-30 2010-09-30 Univ Drexel Mieszaniny polimerów żelujące w podwyższonej temperaturze, do stosowania w materiałach biokompatybilnych
EP1858546A4 (en) 2005-03-04 2009-03-04 Biorexis Pharmaceutical Corp MODIFIED TRANSFERRINFUSION PROTEINS
EP3124614B1 (en) 2007-01-12 2022-06-08 Intrexon Actobiotics NV Lactococcus promoters and uses thereof
JP2009073766A (ja) * 2007-09-21 2009-04-09 Otsuka Pharmaceut Co Ltd 医薬
WO2010111516A2 (en) 2009-03-25 2010-09-30 Whitehead Institute For Biomedical Research Compositions and methods for inhibiting biofilms
US20110033389A1 (en) 2009-04-29 2011-02-10 Zhifeng Chen Modified antibodies for passive immunotherapy
US20110108199A1 (en) 2009-11-10 2011-05-12 Tyco Healthcare Group Lp Hemostatic Tapes and Dispensers Therefor
EP2536754A1 (en) * 2010-02-16 2012-12-26 Novo Nordisk A/S Factor viii fusion protein
CA2830052C (en) 2010-03-31 2018-10-09 Wayne State University Injectable dendrimer hydrogel nanoparticles
KR20110111594A (ko) 2010-04-05 2011-10-12 서울대학교산학협력단 알파-시뉴클레인 유래 곱슬 아밀로이드 섬유의 제조방법, 이를 이용한 하이드로젤의 제조 방법 및 그 이용 방법
US8741417B2 (en) 2010-04-16 2014-06-03 Korea University Research And Business Foundation Films having switchable reflectivity
EP2624874A4 (en) 2010-10-08 2014-04-02 Univ Texas Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
BR112013008957A2 (pt) * 2010-10-15 2019-09-24 Univ Cornell composições e métodos para tratamento de doenças endócrinas, gastrointestinais ou autoimunes
KR20120060442A (ko) 2010-12-02 2012-06-12 가톨릭대학교 산학협력단 위암 진단용 마커로서 ｔｆｆ2의 용도
US9140698B2 (en) * 2011-04-06 2015-09-22 The Board Of Regents Of The University Of Texas System Modulating bacterial MAM polypeptides in pathogenic disease
US9580480B2 (en) * 2011-05-31 2017-02-28 Massachusetts Institute Of Technology Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
CN104271588B (zh) 2011-07-08 2017-10-10 安米林药品有限责任公司 具有增强的作用持续时间和降低的免疫原性的工程改造的多肽
EP2739312B1 (en) 2011-08-03 2017-10-04 Children's Medical Center Corporation A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
WO2013188529A1 (en) 2012-06-15 2013-12-19 Temple University Of The Commonwealth System Of Higher Education Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium
AU2013293092A1 (en) * 2012-07-23 2015-02-26 Zymeworks Inc. Immunoglobulin constructs comprising selective pairing of the light and heavy chains
WO2014078489A1 (en) 2012-11-16 2014-05-22 President And Fellows Of Harvard College Methods and compositions relating to amyloidogenic polypeptides
HRP20191865T1 (hr) * 2013-01-14 2020-01-10 Xencor, Inc. Novi heterodimerni proteini
JP2014156428A (ja) * 2013-02-15 2014-08-28 Univ Of Tokyo 抗体結合タンパク質
WO2014139468A1 (en) * 2013-03-15 2014-09-18 Admark Healthcare, Llc Fusion protein molecules and method of use
US9815871B2 (en) 2013-04-23 2017-11-14 President And Fellows Of Harvard College Genetic reprogramming of bacterial biofilms
WO2015080671A1 (en) 2013-11-30 2015-06-04 Agency For Science, Technology And Research Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing
WO2015097289A1 (en) 2013-12-24 2015-07-02 Vib Vzw Secretion and functional display of chimeric polypeptides
US20150342893A1 (en) 2014-05-29 2015-12-03 Sigmoid Pharma Limited Celecoxib formulations useful for treating colorectal cancer
JP6916524B2 (ja) 2015-04-06 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料
US11098133B2 (en) 2016-05-19 2021-08-24 President And Fellows Of Harvard College Methods of making gels and films using curli nanofibers

Also Published As

Publication number Publication date
US20180258435A1 (en) 2018-09-13
US20200248190A1 (en) 2020-08-06
EP3280397A2 (en) 2018-02-14
WO2016164422A2 (en) 2016-10-13
EP3280397A4 (en) 2018-08-22
US11286491B2 (en) 2022-03-29
JP2021097687A (ja) 2021-07-01
WO2016164422A3 (en) 2017-02-09
JP2018517398A (ja) 2018-07-05
JP7156726B2 (ja) 2022-10-19

Similar Documents

Publication Publication Date Title
JP6916524B2 (ja) 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料
US11352397B2 (en) Genetic reprogramming of bacterial biofilms
Marchesini et al. In search of Brucella abortus type IV secretion substrates: screening and identification of four proteins translocated into host cells through VirB system
Johansson et al. Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose-specific lectin LecB
Waters et al. An amino‐terminal domain of Enterococcus faecalis aggregation substance is required for aggregation, bacterial internalization by epithelial cells and binding to lipoteichoic acid
Pandey et al. Co-regulation of iron metabolism and virulence associated functions by iron and XibR, a novel iron binding transcription factor, in the plant pathogen Xanthomonas
Wang et al. The adhesion of Lactobacillus salivarius REN to a human intestinal epithelial cell line requires s-layer proteins
Wei et al. Outer membrane vesicles secreted by Helicobacter pylori transmitting gastric pathogenic virulence factors
US20160326220A1 (en) Secretion and functional display of chimeric polypeptides
EP3262061B1 (en) Peptides for facilitating secretion and uses thereof
Martinez-Gil et al. YeeJ is an inverse autotransporter from Escherichia coli that binds to peptidoglycan and promotes biofilm formation
Javed et al. A receptor‐binding protein of C ampylobacter jejuni bacteriophage NCTC 12673 recognizes flagellin glycosylated with acetamidino‐modified pseudaminic acid
Gelfat et al. Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917
JP2024508694A (ja) バクテリオファージリシン、そのキメラおよびその使用
Wang et al. A novel secretion and online-cleavage strategy for production of cecropin A in Escherichia coli
Song et al. BsR1, a broad-spectrum antibacterial peptide with potential for plant protection
Hauge et al. A novel proteinaceous molecule produced by Lysinibacillus sp. OF-1 depends on the Ami oligopeptide transporter to kill Streptococcus pneumoniae
Kamoshida et al. Development of a novel bacterial production system for recombinant bioactive proteins completely free from endotoxin contamination
Amro et al. TraC of the conjugative plasmid pKM101 is secreted as a monomer in outer membrane vesicles and stimulates conjugation
Wu et al. The archaic chaperone–usher pathways may depend on donor strand exchange for intersubunit interactions
Estevens Collagen-like sequences as adhesion factors encoded by the pathogenic bacterium Burkholderia cenocepacia: computational analysis and experimental studies
Wong et al. The assembly of a hybrid type IV secretion system by a Crohn’s disease-associated Escherichia coli strain
Guo et al. Functionalizing Nisin with a Sugar Moiety Improves Its Solubility and Results in an Altered Antibacterial Spectrum and Mode of Action
Renn et al. Disulfide bond-mediated passenger domain stalling as a structural probe of autotransporter outer membrane secretion in vivo
Oyama Prospecting Rumen Bacteria for Novel Antimicrobials

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190405

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200127

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200122

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200413

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200727

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20201029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210226

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210226

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210308

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210527

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210615

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210709

R150 Certificate of patent or registration of utility model

Ref document number: 6916524

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250